drugset / Trial / NCT03372941
Hospital Avoidance Strategies for ABSSSI
Phase 4
Terminated
11 enrolled
Washington University School of Medicine
Allergan · collabThe Foundation for Barnes-Jewish Hospital · collab
RandomizedParallel-groupOpen-labelTreatment
Summary
More than 40% of patients presenting with acute bacterial skin and skin structure infection (ABSSSI) to the Barnes-Jewish Hospital (BJH) emergency department (ED) are admitted for intravenous antibiotics. There is growing evidence to suggest that many hospital admissions for uncomplicated ABSSSI due to Gram-positive bacteria could be avoided with an alternative treatment strategy employing newer long-acting antibiotics. Coupled with close outpatient follow-up, such an alternative hospital avoidance strategy has the potential to improve quality and value of care for patients with uncomplicated ABSSSI and optimize use of limited inpatient healthcare resources.
Timeline
- Start
- 2019-03-04
- Primary completion
- 2021-10-14
- Completion
- 2021-10-14
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Dalbavancin | Other / unclassified | — | Intravenous |